Cargando…
Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by progressive fibrosis, vascular impairment and immune abnormalities. In recent years, adipokines (mediators synthetized by adipose tissue) have been indicated as a possible missing link in the pathogenesis of SSc. The ai...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306018/ https://www.ncbi.nlm.nih.gov/pubmed/31667578 http://dx.doi.org/10.1007/s00403-019-01993-y |
_version_ | 1783548575132680192 |
---|---|
author | Stochmal, Anna Czuwara, Joanna Zaremba, Michał Rudnicka, Lidia |
author_facet | Stochmal, Anna Czuwara, Joanna Zaremba, Michał Rudnicka, Lidia |
author_sort | Stochmal, Anna |
collection | PubMed |
description | Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by progressive fibrosis, vascular impairment and immune abnormalities. In recent years, adipokines (mediators synthetized by adipose tissue) have been indicated as a possible missing link in the pathogenesis of SSc. The aim of this study was to investigate the serum concentration of metabolic adipose tissue factors: adiponectin, resistin, leptin and endothelial proteins: endothelin-1, fractalkine and galectin-3 in patients with systemic sclerosis. The study included 100 patients with confirmed SSc diagnosis and 20 healthy individuals. The concentration of respective proteins was determined by enzyme-linked immunosorbent assay. The following markers showed statistically significant increased mean concentrations in patients with SSc in comparison to healthy control: resistin (13.41 vs 8.54 ng/mL; P = 0.0012), endothelin-1 (1.99 vs 1.31 pg/mL; P = 0.0072) and fractalkine (2.93 vs 1.68 ng/mL; P = 0.0007). Elevated serum levels of galectin-3 (4.54 vs 3.26 ng/mL; P = 0.0672) and leptin (19,542 vs 14,210 pg/mL; P = 0.1817) were observed. Decreased concentration of adiponectin was found in patients with SSc (5150 vs 8847 pg/mL; P = 0.0001). Fractalkine and galectin-3 levels were significantly higher in diffuse cutaneous SSc than limited cutaneous SSc subset (3.93 ng/mL vs 2.58 ng/mL, P = 0.0018; 6.86 ng/mL vs 3.78 ng/mL, P = 0.0008, respectively) and correlated positively with modified Rodnan Skin Score in total SSc patients (r = 0.376, P = 0.0009; r = 0.236, P = 0.018, respectively). In conclusion, an increased serum level of resistin associated with increased endothelin-1 and fractalkine level and decreased adiponectin level may indicate a significant role of the adipose tissue in the development and progression of vascular abnormalities in patients with systemic sclerosis. Fractalkine and galectin-3 may participate in promoting and exacerbating the fibrotic process in SSc. |
format | Online Article Text |
id | pubmed-7306018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73060182020-06-22 Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis Stochmal, Anna Czuwara, Joanna Zaremba, Michał Rudnicka, Lidia Arch Dermatol Res Concise Communications Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by progressive fibrosis, vascular impairment and immune abnormalities. In recent years, adipokines (mediators synthetized by adipose tissue) have been indicated as a possible missing link in the pathogenesis of SSc. The aim of this study was to investigate the serum concentration of metabolic adipose tissue factors: adiponectin, resistin, leptin and endothelial proteins: endothelin-1, fractalkine and galectin-3 in patients with systemic sclerosis. The study included 100 patients with confirmed SSc diagnosis and 20 healthy individuals. The concentration of respective proteins was determined by enzyme-linked immunosorbent assay. The following markers showed statistically significant increased mean concentrations in patients with SSc in comparison to healthy control: resistin (13.41 vs 8.54 ng/mL; P = 0.0012), endothelin-1 (1.99 vs 1.31 pg/mL; P = 0.0072) and fractalkine (2.93 vs 1.68 ng/mL; P = 0.0007). Elevated serum levels of galectin-3 (4.54 vs 3.26 ng/mL; P = 0.0672) and leptin (19,542 vs 14,210 pg/mL; P = 0.1817) were observed. Decreased concentration of adiponectin was found in patients with SSc (5150 vs 8847 pg/mL; P = 0.0001). Fractalkine and galectin-3 levels were significantly higher in diffuse cutaneous SSc than limited cutaneous SSc subset (3.93 ng/mL vs 2.58 ng/mL, P = 0.0018; 6.86 ng/mL vs 3.78 ng/mL, P = 0.0008, respectively) and correlated positively with modified Rodnan Skin Score in total SSc patients (r = 0.376, P = 0.0009; r = 0.236, P = 0.018, respectively). In conclusion, an increased serum level of resistin associated with increased endothelin-1 and fractalkine level and decreased adiponectin level may indicate a significant role of the adipose tissue in the development and progression of vascular abnormalities in patients with systemic sclerosis. Fractalkine and galectin-3 may participate in promoting and exacerbating the fibrotic process in SSc. Springer Berlin Heidelberg 2019-10-30 2020 /pmc/articles/PMC7306018/ /pubmed/31667578 http://dx.doi.org/10.1007/s00403-019-01993-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Concise Communications Stochmal, Anna Czuwara, Joanna Zaremba, Michał Rudnicka, Lidia Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis |
title | Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis |
title_full | Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis |
title_fullStr | Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis |
title_full_unstemmed | Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis |
title_short | Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis |
title_sort | altered serum level of metabolic and endothelial factors in patients with systemic sclerosis |
topic | Concise Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306018/ https://www.ncbi.nlm.nih.gov/pubmed/31667578 http://dx.doi.org/10.1007/s00403-019-01993-y |
work_keys_str_mv | AT stochmalanna alteredserumlevelofmetabolicandendothelialfactorsinpatientswithsystemicsclerosis AT czuwarajoanna alteredserumlevelofmetabolicandendothelialfactorsinpatientswithsystemicsclerosis AT zarembamichał alteredserumlevelofmetabolicandendothelialfactorsinpatientswithsystemicsclerosis AT rudnickalidia alteredserumlevelofmetabolicandendothelialfactorsinpatientswithsystemicsclerosis |